News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
foto oyrzon
ORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophrenia
Healthcare
Clinical Trial Application approved by Spanish Drug Agency  Primary objectives: to assess the…
Partners - Oryzon Genomics
FOTO ORYZON
ORYZON presents safety and efficacy data of vafidemstat from the Phase II ESCAPE trial in severe CoVID-19 patients at ECCMID-2021
Healthcare
Vafidemstat was safe and well tolerated  Confirmed anti-inflammatory activity of vafidemstat…
Partners - Oryzon Genomics
acorys equipment
Corify Care raises €2.35M to translate its cardiac mapping technology to the market
Healthcare · Personalized medicine · Financing
The investment round is led by Clave Capital, counting with investment from CDTI through its…
Partners - Corify Care
Ysios Capital anuncia la salida a bolsa en el NASDAQ de su compañía participada CVRx, Inc.
Ysios Capital’s portfolio company CVRx Inc. prices IPO on NASDAQ
This is a major achievement for Ysios as CVRx is its fifth portfolio company to be listed on NASDAQ…
Partners - Ysios Capital Partners
jjj
Preparation is key: brief checklist how to bring IVD MD into compliance with EU IVDR
El IVDR evolucionó a partir de la IVDD para establecer un “marco más sólido, transparente,…
Partners - NAMSA
Moirai Biodesign Team
Moirai Biodesign creates an innovative synthetic RNA design software
Healthcare · Drug discovery · Advanced therapies
Moirai Biodesign – a biotech startup located at the Barcelona Scientific Park, pioneer in the…
Partners - Parc Científic de Barcelona
edificio oryzon
ORYZON to present new clinical data and corporate updates at international conferences in June and July
Healthcare
Emerging Biotech Company Showcase organizado por NewYorkBIO y la Bolsa de Nueva York Spring…
Partners - Oryzon Genomics
foto oryzon
ORYZON announces FDA approval of IND for PORTICO, a Phase IIb trial with vafidemstat in Borderline Personality Disorder
Healthcare
Recruitment ongoing in Europe. Primary objectives: to assess the effect of vafidemstat to…
Partners - Oryzon Genomics
foto oryzon 2
ORYZON presents iadademstat ALICE 30-month data at EHA-2021, confirming positive and robust efficacy in combination with azacitidine in AML
Healthcare
Robust signals of clinical efficacy, with ORR of 83%, of which 67% are CR/CRi and five…
Partners - Oryzon Genomics